Division of rheumatology & immunology

MCRC Leadership

Director

Gary Gilkeson, MD

Dr Gilkeson leads a very productive SLE research group composed of basic and clinical investigators with significant extramural research support.  He has demonstrated an ability to collaborate with a wide array of investigators at MUSC, other institutions and in other countries.  Dr. Gilkeson directs the SCTR Clinical and Translational Research Center, is Associate Dean of Faculty Affairs and Faculty Development in the College of Medicine.

Associate Director

Richard Silver, MD

Dr. Silver has a longstanding interest and commitment to patient care and clinical research, particularly related to SSc.  Since he became the Director of the Division of Rheumatology in 1995, the clinical activities and extramural research conducted by members of the Division have increased significantly.  Dr. Silver is actively engaged in multi-center scleroderma research activities at national and international levels. 

Director, Methodology Core

Paul Nietert, PhD

Dr. Nietert focuses his research in the area of health services research.  He is involved in lung cancer research, where he studies the impact of the latest imaging technologies on diagnosis and management of this disease.  Dr. Nietert also directs the Collaborative Unit within the Department of Biostatistics, Bioinformatics, and Epidemiology at MUSC. 

Associate Director, Methodology Core

Viswanathan Ramakrishnan, PhD

Dr. Ramakrishnan (Ramesh) has provided biostatistics expertise to a wide range of scientists working in many areas of medicine. His methodological work has included clinical trial designs, missing data methods, longitudinal data analysis, twin studies, and so on. As the co-director of the MCRC biostatistics core he is committed to research in SLE and SSc. He has mentored numerous doctoral students and faculty. He is the graduate program director for the department of public health sciences.

PI, Patient Resource Core

James Oates, MD

Dr. Oates' clinical and research interests are focused on systemic lupus erythematosus.  He is involved in clinical trials of therapies for systemic lupus erythematosus and lupus nephritis and is the principal investigator on several studies at MUSC involving noninvasive markers of disease and mechanisms through which disease severity may increase among African-Americans.

PI, Patient Resource Core

Edwin Smith, MD

 Dr. Smith's particular clinical and research interests include scleroderma and rheumatoid arthritis.  His teaching interests include lectures to students, medical residents, and primary care physicians, including CME courses.

PI, Project 1

Galina Bogatkevich, PhD, MD

Dr. Bogatkevich’s research interests focus on understanding the cellular and molecular mechanisms of pulmonary fibrosis in scleroderma patients. The ongoing research in the laboratory can be subdivided in three major projects: 1) myofibroblasts in scleroderma lung disease, 2) CTGF-interacting proteins in scleroderma pulmonary fibrosis, and 3) comparative proteomic analysis of fibrotic and healthy lungs and epithelial lining fluid that covers the airways.

PI, Project 2

Diane Kamen, MD, MSCR

Dr. Kamen has had a longstanding interest in the clinical treatment of and research in understanding the natural history of autoimmune disorders. Her clinical and research interests remain focused on Systemic Lupus Erythematosus and she is an active member of the M.U.S.C.L.E. Research Group.

 
 
 

© Medical University of South Carolina | 171 Ashley Avenue, Charleston, SC 29425